Company / Revenue
Edesa Biotech, Inc. Revenue History
FY2014-FY2021 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$328.8K
FY2021
5-year range
$228.3K / $758.7K
FY2017-FY2021
Trend
-20.0%
vs FY2020
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Revenue has fluctuated over the past 7 years, ranging from $228,287 in FY2018 to $758,689 in FY2017.
Based on SEC 10-K filings.
$328,801 in FY2021 with a 5-year CAGR of -2.4%.
Improved from $228,287 to $328,801 over the past 3 years.
Revenue over time
Growth rates
- 3-Year CAGR
- +12.9%
- 5-Year CAGR
- -2.4%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -2.4%, indicating a declining trend.
- In FY2021, revenue decreased 20.0% year-over-year.
- Peak revenue was recorded in FY2017.
- Lowest revenue in the period was in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.47 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2021 | $328.8K | -20.0% |
| FY2020 | $410.9K | +80.0% |
| FY2018 | $228.3K | -69.9% |
| FY2017 | $758.7K | +103.9% |
| FY2016 | $372.1K | -31.8% |
| FY2015 | $545.5K | +90.7% |
| FY2014 | $286.1K | - |
As of FY2021 · SEC 10-K · Updated Jun 24, 2026